PrP immunohistochemistry: Different protocols, including a procedure for long formalin fixation, and a proposed schematic classification for deposits in sporadic Creutzfeldt-Jakob disease

Microscopy Research and Technique

Volumn 50, Issue 1, 2000, Pages 26-31

  Privat, Nicolas ^a   Sazdovitch, Véronique ^a   Seilhean, Danielle ^a   Laplanche, Jean Louis ^b   Hauw, Jean Jacques ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Diagnostic; Immunohistochemistry; Prion diseases; Proteinase K; PrP

Indexed keywords

DIAGNOSIS; FORMALDEHYDE; NEURODEGENERATIVE DISEASES; PHOSPHORUS COMPOUNDS; PRASEODYMIUM COMPOUNDS; TISSUE;

CREUTZFELDT-JAKOB DISEASE; DIAGNOSTIC; DIFFERENT PROTOCOLS; FORMALIN FIXATION; IMMUNOHISTOCHEMISTRY; LOW SENSITIVITY; PRION DISEASE; PROTEINASE K; SPONGIFORM ENCEPHALOPATHIES; SPORADICS;

PARAFFINS;

ANTIBODY; FORMALDEHYDE; FORMIC ACID; GUANIDINE DERIVATIVE; PARAFFIN; PRION PROTEIN; PROTEINASE K;

ANTIBODY LABELING; ARTICLE; AUTOCLAVE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; ENZYME DEGRADATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROPATHOLOGY; PRION DISEASE; PRIORITY JOURNAL; TISSUE FIXATION;

EID: 0034235125     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0029(20000701)50:1<26::AID-JEMT5>3.0.CO;2-S     Document Type: Article

References (36)

1. Antoine JC, Laplanche J-L, Mosnier J-F, Beaudry P, Chatelain J, Michel D. 1996. Demyelinating peripheral neuropathy with Creutzfeldt-Jakob disease and mutation at the codon 200 of the prion protein gene. Neurology 46:1123-1127.
2. Bell JE, Gentleman SM, Ironside JW, McCardle L, Lantos PL, Doey L, Lowe J, Fergusson J, Luthert P, McQuaid S, Allen IV. 1997. Prion protein immunocytochemistry: UK five centre consensus report. Neuropathol Appl Neurobiol 23:26-35.
3. Brown P, Wolff A, Gajdusek DC. 1990. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 40:887-890.
4. Budka H, Aguzzi A, Brown P, Brucher J-M, Bugiani O, Gullotta F, Haltia M, Hauw J-J, Ironside JW, Jellinger K, Kretzschmar HA, Lantos PL, Masullo C, Schlote W, Tateishi J, Weller RO. 1995. Neuropathological diagnostic criteria for Creutzfeldt-Jakob (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5:469-456.
5. Chazot G, Broussolle E, Lapras Cl, Blätter T, Aguzzi A, Kopp N. 1996. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 347:1181.
6. Collinge J, Palmer M. 1996. Prion Diseases. Oxford University Press
7. Davison F, An SF, Scaravilli F. (1996) Quantification of HIV DNA in the brain by PCR: differences between fresh frozen and formalin fixed tissue. J Clin Pathol 49:425-427.
8. DeArmond SJ, Mobley WC, DeMott DL, Barry RA, Beckstead JH, Prusiner SB. 1987. Changes in the localization of brain prion proteins during scrapie infection. Neurology 37:1271-1280.
9. Doi-Yi R, Kitamoto T, Tateishi J. 1991. Immunoreactivity of cerebral amyloidosis is enhanced by protein denaturation treatments. Acta Neuropathol 82:260-265.
10. Guiroy DC, Yanagihara R, Gajdusek DC. 1991. Localization of amyloidogenic proteins and sulfated glycosaminoglycans in nontransmissible and transmissible cerebral amyloidoses. Acta Neuropathol 82:87-92.
11. Haritani M, Spencer YI, Wells GAH. 1994. Hydrated autoclave pre-treatment enhancement of prion protein reactivity m formalin-fixed bovine spongiform encephalopathy-affected brain. Acta Neuropathol 87:86-90.
12. Hashimoto K, Mannen T, Nobuyuki N. 1992. Immunohistochemical study of kuru plaques using antibodies against synthetic prion protein peptides. Acta Neuropathol 83: 613-617.
13. Hauw JJ, Sazdovitch V, Seilhean D, Camilleri S, Lazarini F, Delasnerie-Lauprêtre N, Duyckaerts C. 1996. The nosology and neuropathology of human conditions related to unconventional agents or Prions. Eur J Neurol 3:487-499.
14. Hauw JJ, Sazdovitch V, Laplanche JL, Kopp N, J Privat N, Delasnerie-Lauprêtre N, Brandel JP, Deslys JP, Laplanche JL, Dormont D, Alpérovitch A. 1999a. Phenotypic variations and Prion protein genotype in sporadic Creutzfeldt-Jakob disease: a neuropathological study. Neurology 52(Suppl 2):A418.
15. Hauw JJ, Sazdovitch V, Privat N, Seilhean D, Kopp N, Lauprêtre N, Brandel JP, Deslys JP, Laplanche JL , Alpérovitch A. 1999b. The significance of morula-type spongiform change in sporadic Creutzfeldt-Jakob disease. A study in 70 patients. Neuropathol Appl Neurobiol 25 (Suppl 1):62.
16. Hauw JJ, Sazdovitch V, Laplanche JL , Peoc'h K, Kopp N, Kemeny, J Privat N, Delasnerie-Lauprêtre N, Brandel JP, Deslys JP, Dormont D, Alpérovitch A. 2000. Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene. Neurology 54:1641-1646.
17. Hayward PAR, Bell JE, Ironside JW. 1994. Prion protein immunocytochemistry: reliable protocols for the investigation of Creutzfeldt-jacob disease. Neuropathol Appl Neurobiol 20:375-383.
18. Hegyi I, Hainfellner JA, Flicker H, Ironside J, Hauw JJ, Tateishi J, Haltia M, Bugiani O, Aguzzi A, Budka H. 1997. Prion protein immunocytochemistry: reliable staining protocol, immunomorphology, and diagnostic pitfalls. Clinical Neuropathol 16:262-263.
19. Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, Wisniewskj HM, Diringer H. 1987. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61:3688-3693.
20. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB. 1987. Methods in laboratory investigation: formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57:2:230-236.
21. Kitamoto T, Shin RW, Doh-ura K, Tomokane N, Miyazono M, Muramoto T, Tateishi J. 1992a. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. A. J Pathol 140: 1285-1294.
22. Kitamoto T, Doh-ura K, Muramoto T, Miyazono M, Tateishi J. 1992b. The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system. Am J Pathol 141:271-277.
23. Kretzschmar HA, Kitamoto T, Doerr-Schott, Mehraein P, Tateishi J. 1991. Diffuse deposition of immunohistochemically labeled prion protein in the granular layer of the cerebellum in a patient with Creutzfeldt-Jakob disease. Acta Neuropathol (Berl) 82:536-540.
24. Kretzchmar HA, Ironside JW, DeArmond SJ, Tateishi J. 1996. Diagnostic criteria for sporadic Creutzfeld-Jakob disease. Arch Neurol 53:913-920.
25. Litvan I, Hauw J-J, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger J, Anderson DW. 1996. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55:97-105.
26. MacDonald ST, Sutherland K, Ironside JW. 1996. A quantitative and qualitative analysis of prion protein immunohistochemical staining in Creutzfeldt-jacob disease using four anti prion protein antibodies. Neurodegeneration 5: 87-94.
27. Masters CL, Harris JO, Gajdusek DC, Gibbs CJ Jr, Bernoulli C, Asher DM. 1979. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 5:177-188.
28. McBride PA, Bruce ME, Fraser H. 1988. Immunostaining of scrapie cerebral amyloid plaques with antisera raised to scrapie-associated fibrils (SAF). Neuropath Appl Neurobiol 14: 325-336.
29. McKeith IG, Galasko D, Kosaka K, Perry E, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, de Vos RAI, Wilcock GK, Jellinger KA, Perry RH. 1996. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113-1124.
30. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. 1991. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 41;479-486.
31. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AA, Trojanowski JQ, Petersen RB, Gambetti P. 1996. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39:767-778.
32. Parchi P, Giese A, Capellarri S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Guetti B, Gambetti P, Kretzschmar H. 1999. Classification of sporadic Creutzfeldt-Jakob disease based on lolecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224-233.
33. Schulz-Schaeffer WJ, Giese A, Windl O, Kretzschmar H. 1996. Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease. Clin Neuropathol 15:353-357.
34. Serban D, Taraboulos A, DeArmond SJ, Prusiner SB. 1990. Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology 40:110-117.
35. Taylor D M, Brown J M, Fernie K, McConnell I. 1997. The effect of formic acid on BSE and scapie infectivity in fixed and unfixed brain-tissue. Vet Microbiol 58:167-174.
36. Will RG, Ironside JW, Zeidler M et al. 1996. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921-925.